Finance

Beta
Lists
LTRN:NASDAQ
Lantern Pharma Inc
$3.97
-1.24%
(-0.050) 1D
$3.96
-0.29% (-0.011)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LTRN...
Open
$4.07
High
$4.18
Low
$3.90
Mkt. cap
50.65M
Avg. vol.
215.71K
Volume
86.80K
52-wk high
$5.74
52-wk low
$1.11
EPS
-$1.45
Beta
2.30
Shares outstanding
12.76M
No. of employees
16
Open
$4.07
High
$4.18
Low
$3.90
Mkt. cap
50.65M
Avg. vol.
215.71K
Volume
86.80K
52-wk high
$5.74
52-wk low
$1.11
EPS
-$1.45
Beta
2.30
Shares outstanding
12.76M
No. of employees
16
News stories
From sources across the web
About Lantern Pharma Inc
CEO-
Employees16
Founded2013
HeadquartersDallas, Texas, United States
SectorBiotechnology
Websitelanternpharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to LTRN in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for LTRN in the last 3 months
Highest
Current $3.97
$25.00 (+529.72%)
Average
$25.00 (+529.72%)
Lowest
$25.00 (+529.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chad Messer
Lake Street
Buy
Maintained
$25.00
+529.7%
05/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.07M
2.44M
2.74M
1.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.58M
1.91M
1.46M
1.68M
Operating expense
4.65M
4.35M
4.20M
3.41M
Total operating expenses
4.65M
4.35M
4.20M
3.41M
Operating income
-4.65M
-4.35M
-4.20M
-3.41M
Other non operating income
206.14K
71.46K
63.47K
93.37K
EBT including unusual items
-4.33M
-4.18M
-4.07M
-3.33M
EBT excluding unusual items
-4.33M
-4.18M
-4.07M
-3.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.33M
-4.18M
-4.07M
-3.33M
Net profit margin
-
-
-
-
Earnings per share
-0.40
-0.39
-0.36
-0.30
Interest and investment income
114.74K
100.92K
72.48K
42.16K
Interest expense
-
-
-
-
Net interest expenses
114.74K
100.92K
72.48K
42.16K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.65M
-4.35M
-4.20M
-3.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer